FIVE Validation Receives SINDUSFARMA 2023 Award.

Sindusfarma was founded in 1933 and is known as the Union of the Pharmaceutical Products Industry in the State of São Paulo.

The main objective of this organization is to defend pharmaceutical interests mainly in São Paulo and throughout the country of Brazil.

Annually, the union holds a ceremonial event to announce the winners of the Sindusfarma Quality Awards Ceremony, which culminated in its 27th anniversary in 2023.

The Sindusfarma Awards Ceremony aims to recognize outstanding companies across the country in Good Manufacturing Practices.

Since 2018, FIVE Validation has enrolled to participate in this awards ceremony, which takes place in several selection phases. The first is the voting of the companies within the pharmaceutical industry to select those who will be ranked in the second phase, and the second phase consists of auditors auditing each elected candidate’s quality system.

In 2020, FIVE Validation won 1st place in the category of "Provision of Production Services".

Even before the pandemic, FIVE had been operating within a digital and remote model, including deliveries of validation studies to clients and with an internal quality management system process.

There were already many benefits to a paperless approach regardless of the global situation that soon followed.

In 2023, Sindusfarma created the category "Software and Solutions for Production Equipment". As a result, FIVE won 1st place in this new category and 2nd place in the "Provision of Production Services" category.

FIVE was recognized in this year’s ceremony for its outstanding implementation of ISO 27001:2022 and the qualification of its infrastructure.


Looking ahead, the goal for the last quarter of this year is to obtain both certifications and contract a preparatory audit to increasingly ensure that FIVE meets key quality and information security requirements.

Under the leadership of Sílvia Martins and João Gomes, the company is continuing its process of expanding internationally.

The USA and Europe is the region which contains the most the pharmaceutical industries. So, the progress of the internalization process will allow FIVE to serve a greater number of clients that stand out in the sector.

This way, FIVE will positively impact new, relevant clients in the world with its cloud validation solution.

Thus, the recognition received in Brazil by Sindusfarma pertains to the company's process of expanding internationally. ANVISA is one of the largest sanitation regulatory agencies in the world and Sindusfarma carries out its awards ceremony in compliance with ANVISA, which in turn implies that FIVE is better prepared to meet GxP requirements.

Among the new challenges for FIVE’s future plans, we can list the following: consolidation of the implementation of ISO 27001:2022;  increasing participation in prestigious international events (FIVE was already nominated finalist in CPhI Pharma Awards list in Frankfurt 2022);  consolidation of the Customer Success area;  and the finalization of its infrastructure qualification.